High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

Cancer Cell
Daniel R CarrascoRonald A Depinho

Abstract

To identify genetic events underlying the genesis and progression of multiple myeloma (MM), we conducted a high-resolution analysis of recurrent copy number alterations (CNAs) and expression profiles in a collection of MM cell lines and outcome-annotated clinical specimens. Attesting to the molecular heterogeneity of MM, unsupervised classification using nonnegative matrix factorization (NMF) designed for array comparative genomic hybridization (aCGH) analysis uncovered distinct genomic subtypes. Additionally, we defined 87 discrete minimal common regions (MCRs) within recurrent and highly focal CNAs. Further integration with expression data generated a refined list of MM gene candidates residing within these MCRs, thereby providing a genomic framework for dissection of disease pathogenesis, improved clinical management, and initiation of targeted drug discovery for specific MM patients.

References

Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Oct 19, 2001·Oncogene·P L Bergsagel, W M Kuehl
May 7, 2002·Nature Reviews. Cancer·W Michael Kuehl, P Leif Bergsagel
Sep 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jonathan R PollackPatrick O Brown
Dec 4, 2002·Genes, Chromosomes & Cancer·Manal O ElnenaeiDaniel Catovsky
Mar 3, 2004·Cancer Research·Rafael FonsecaHerve Avet-Loiseau
Mar 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jean-Philippe BrunetJill P Mesirov
Apr 28, 2004·The American Journal of Pathology·Se-Hwa KimZorina S Galis
Jun 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Andrew J AguirreLynda Chin
Jul 9, 2004·Biochimica Et Biophysica Acta·Mohamed Abdelhaleem
Jul 27, 2004·Science·Jonathan SebatMichael Wigler
Oct 12, 2004·Cancer Genetics and Cytogenetics·Bernd WullichVolker Jung
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Oct 27, 2004·Nature Medicine·Kwai Wa ChengGordon B Mills
Nov 16, 2004·Cancer Cell·Constantine S MitsiadesKenneth C Anderson
Dec 28, 2004·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Mark van DuinColin Collins
Apr 21, 2005·Seminars in Cell & Developmental Biology·Keiichi I Nakayama, Keiko Nakayama
May 12, 2005·Blood·Ya-Wei QiangStuart Rudikoff
Jun 10, 2005·Nature·Lin HeScott M Hammond
Jun 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Giovanni TononRonald A Depinho
Jul 20, 2005·Best Practice & Research. Clinical Haematology·Paul G RichardsonKenneth C Anderson
Aug 23, 2005·Leukemia Research·Hong ChangA Keith Stewart
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Leif Bergsagel, W Michael Kuehl
Oct 11, 2005·Mayo Clinic Proceedings·S Vincent Rajkumar, Robert A Kyle
Mar 10, 2006·The New England Journal of Medicine·Bart BarlogieJohn Crowley

❮ Previous
Next ❯

Citations

Jan 6, 2007·Annals of Hematology·Francesco A PiazzaGianpietro Semenzato
Jun 12, 2012·Cancer Metastasis Reviews·Tomoo Iwakuma, Neeraj Agarwal
Sep 2, 2011·International Journal of Hematology·Teru Hideshima, Kenneth C Anderson
Mar 4, 2011·European Journal of Human Genetics : EJHG·Herbert PangStéphane Minvielle
Apr 27, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Linda D CooleyUNKNOWN Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee
Oct 3, 2009·Leukemia·R FonsecaUNKNOWN International Myeloma Working Group
Jun 24, 2008·Nature·Arthur L ShafferLouis M Staudt
Jul 25, 2007·Nature Reviews. Cancer·Teru HideshimaKenneth C Anderson
May 23, 2009·Nature Reviews. Cancer·Jaap Kool, Anton Berns
Apr 13, 2012·Nature Reviews. Cancer·Gareth J MorganFaith E Davies
Jan 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Masahisa JinushiGlenn Dranoff
Jun 3, 2008·Nucleic Acids Research·E Mejía-RoaA Pascual-Montano
May 31, 2007·Current Opinion in Hematology·Travis Henry, Rafael Fonseca
Dec 17, 2009·The Cancer Journal·Sigurdur Yngvi KristinssonVincent S Rajkumar
Aug 24, 2012·Science Translational Medicine·Kohichi TakadaDaniel Ruben Carrasco
Oct 7, 2011·Journal of Oncology·Marc J BraunsteinOlcay Batuman
Jun 6, 2013·TheScientificWorldJournal·Yeuntyng LaiTatsuya Akutsu
Apr 16, 2009·Cancer Research·Hyun Goo WooSnorri S Thorgeirsson
Aug 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bart BuringtonJohn D Shaughnessy
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola E LeoneGareth J Morgan
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicholas J DickensGareth J Morgan
Mar 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nikhil C Munshi, Hervé Avet-Loiseau
Jan 17, 2012·Molecular Cancer Therapeutics·Douglas W McMillinConstantine S Mitsiades
Dec 17, 2008·Hematology·Nikhil C Munshi
Jan 18, 2011·Hematology·Hervé Avet-Loiseau
Dec 14, 2011·Hematology·Kenneth C Anderson
May 27, 2006·Blood·Fenghuang ZhanJohn D Shaughnessy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.